XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue and Contract Acquisition Costs
 9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Revenue and Contract Acquisition Costs Revenue and Contract Acquisition Costs
The following table summarizes the Company’s disaggregated revenue:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2023202220232022
U.S. Omnipod$320.6 $238.1 $856.4 $608.6 
International Omnipod101.4 88.0 303.7 272.8 
Total Omnipod422.0 326.1 1,160.1 881.4 
Drug Delivery10.7 14.7 27.2 54.2 
Total revenue$432.7 $340.8 $1,187.3 $935.6 
The percentages of total revenue for customers that represent 10% or more of total revenue were as follows:
Three Months Ended September 30,Nine Months Ended September 30,

2023202220232022
Distributor A26%17%27%18%
Distributor B21%18%18%16%
Distributor D23%17%23%15%
Distributor E
11%10%**
* Represents less than 10% of revenue for the period.
Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:
(in millions)
September 30, 2023December 31, 2022
Accrued expenses and other current liabilities$13.8 $16.1 
Other liabilities1.8 1.6 
Total deferred revenue$15.6 $17.7 
Revenue recognized from amounts included in deferred revenue at the beginning of each respective period was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2023202220232022
Deferred revenue recognized$3.0 $0.3 $15.2 $1.8 
Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:
(in millions)September 30, 2023December 31, 2022
Prepaid expenses and other current assets$16.4 $15.2 
Other assets32.4 31.3 
Total capitalized contract acquisition costs, net$48.8 $46.5 
The Company recognized $4.1 million and $3.7 million of amortization of capitalized contract acquisition costs during the three months ended September 30, 2023 and 2022, respectively, and recognized $12.1 million and $10.7 million of amortization of capitalized contract acquisition costs during the nine months ended September 30, 2023 and 2022, respectively.